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Meeting Dr Montgomery
In 2016, Dr Montgomery joined the New York University Langone Health, where he and transplant administrator, Brigitte Sullivan, were transforming a transplant program into a transplant institute. I met him there and began the interview with what influenced his decision to become a physician, his response was different from others I had interviewed.
On Becoming a Physician
Dr Montgomery described his initial plans to become a veterinarian. However, his father became seriously ill with congestive heart failure and died when Dr Montgomery was a teen. He remembers the events of this illness and visiting his father in the hospital during his frequent readmissions over a 2-year period. This experience impacted his life and decisions made with his career. Interestingly, heart transplant was discussed by a cardiologist during his father's illness; however, due to his age (50), he was not considered a candidate according to guidelines in the early 1970s as outcomes were poor. Outcomes did not really improve until cyclosporine was released in the United States in 1983. 2, 3 Much of Dr Montgomery's early life and education has been in New York State. He was born in Buffalo, New York, graduated from St Lawrence University magna cum laude with a Bachelor of Science in Biology, and graduated from the University of Rochester School of Medicine with honors. To increase his knowledge of immune function, he pursued a Doctorate of Philosophy at Balliol College at the University of Oxford. His surgical training and transplant fellowship were both completed at Johns Hopkins University in Baltimore, Maryland, where he received many honors for his work in transplantation. During his undergraduate studies, he found bioethics and animal physiology to be most interesting to him. He looked deeply in thought as he described why bioethics was most interesting to him, describing several instances he experienced during his training.
It was his father's illness, seeing him in the hospital and experiencing his death, that influenced Dr Montgomery's decision to become a physician. Of course, I had to ask why he chose abdominal transplantation rather than heart transplantation as his path during his fellowship. He smiled as if he knew that question was coming. He chose to focus on kidney transplantation because he wanted to be immersed in transplantation full time. Heart surgeons performed other surgeries in addition to transplantation, and he wanted to be more focused on immune function and the impact of transplantation on the immune system. At Balliol College at the University of Oxford in England, Dr Montgomery did just that. He focused on molecular immunology. Classmates at Oxford included 2 other American physicians: Joren Madsen, MD, a heart transplant surgeon at Massachusetts General Hospital in Boston, and Chris Larsen, MD, a kidney transplant surgeon at Emory University. That focus in molecular immunology at Oxford seems most appropriate for the work each is now doing in transplantation.
Increasing Patient Access to Transplantation
Following his surgical fellowship at Johns Hopkins, Dr Montgomery joined the faculty and began his clinical practice as a transplant surgeon. He later became Director of the Comprehensive Transplant Center at Johns Hopkins and was part of the team that developed a laparoscopic procedure to remove a kidney from a living kidney donor in 1995. By 1996, the surgical team published a report on their first 3 living donors using the laparoscopic technique. They described an average ischemic time of less than 5 minutes, capturing the attention of the kidney transplant community. Most ischemic times were reported in hours. To have an ischemic time recorded in minutes would definitely have a more positive outcome on long-term kidney function in recipients.
In 2004, Dr Montgomery and his team at Johns Hopkins described a kidney transplant in a patient who was ABO incompatible with the donor and also had a positive crossmatch. The preconditioning treatment of plasmapheresis and low-dose Cytomegalovirus (CMV) hyperimmune globulin (IVIg) was used to reduce donor-specific antibody to a safe level. There were no hyperacute rejections. 4 This work provided clinicians with new hope for increasing transplantation options for patients. Prior to this, preconditioning for ABO incompatible transplantation required a splenectomy.
5 Dr Montgomery's group showed that adding the B-cell ablative monoclonal antibody, anti-CD 20 (Rituximab), to the protocol using plasmapheresis and IVIg, they were able to avoid splenectomy and successfully perform ABO incompatible transplantation. 5, 6 These protocols are also applied to highly sensitized patients, thus allowing individuals with previous transplants, multiparous women, or those with previous blood transfusions to be considered for transplantation. Dr Montgomery's team also led the way with the first 2-way domino-paired exchange that led to 3-, 4-, and 8-way paired exchanges that have now become part of many kidney transplant programs worldwide. With the use of donor exchanges and desensitizing protocols, transplantation has become a possibility for highly sensitized patients who are often denied transplant due to their highly reactive immune system.
Conclusion
In discussing his influence on many medical students, surgical residents and fellows, I asked whether there was anyone who influenced him during his career. Without hesitation he stated Dr Starzl. As he talked about Dr Starzl, he was most impressed with the accomplishments he made in his life. Dr Starzl believed we went down the wrong road when we started immunosuppression and felt the goal for transplant was tolerance. He explained that Dr Starzl is one of the most cited authors in transplantation and that he was a big fan of opera. Dr Montgomery has become an opera aficionado since he married to Denyce Graves, the beautiful and highly esteemed operatic mezzo-soprano! When asked what challenges him most about transplantation, Dr Montgomery stated, again, without hesitation, "As a (transplant) surgeon, you are a shepherd of a scarce resource and an advocate for your patients. I enjoy the tension that creates. Your ideas, thoughts, and concerns extend beyond the people you can directly impact. You must learn how to be judicious and equitable in the discharge of your duties as a transplant surgeon. While I have the duty to take care of one patient at a time, I must also have the ability to develop new techniques that impact on the greatest number of patients." Dr Montgomery certainly fits the title of this series: Courage and Character, Leaders and Legends. His fourth-grade teacher may have seen the development of that courage and character when she wrote on his report card "Bobby doesn't think the rules apply to him." 7 He, like others in this series, has not played by standard rules. They not only think outside the box, but they play differently in the sandbox. And for the patients . . . that has been a life saver and life changer. Thanks Dr Montgomery! Linda Ohler, MSN, RN, CCTC, FAAN, FAST New York University Langone Transplant Institute
